Drug
INOpulse®
Status:
Phase 3
Condition:
Pulmonary Hypertension
Intervention Type:
Inhaled Drug
Funder Type:
Industry
Drug Details
iNO stands for Inhaled Nitric Oxide. Nitric oxide is a colorless gas that is formed by the oxidation of nitrogen.
Study Purpose
A randomized, double-blind, placebo-controlled dose escalation and verification study to assess the safety and efficacy of pulsed inhaled nitric oxide (iNO) versus placebo in subjects at risk for pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy. (REBUILD)